|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: Japan) |
IUPAC Name ![]() |
| ethyl 4-[6-(diaminomethylideneamino)hexanoyloxy]benzoate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 3988 | gabexate |
Database Links ![]() |
|
| CAS Registry No. | 39492-01-8 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL87563 |
| PubChem CID | 3447 |
| Search Google for chemical match using the InChIKey | YKGYIDJEEQRWQH-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | YKGYIDJEEQRWQH |
| Search PubMed clinical trials | gabexate |
| Search PubMed titles | gabexate |
| Search PubMed titles/abstracts | gabexate |
| Wikipedia | Gabexate |
| Comments |
| Gabexate (as the mesylate) is an inhibitor of trypsin-like serine proteases and is used in the treatment of pancreatitis, disseminated intravascular coagulation and as a regional anticoagulant for hemodialysis. The mesylate is PubChem CID 6604561. |